Comparing Absolute Lymphocyte Count to Total Lymphocyte Count, as a CD4 T Cell Surrogate, to Initiate Antiretroviral Therapy

BACKGROUND: The high cost of CD4 count estimation in resource-limited settings is a major obstacle in initiating patients on highly active antiretroviral therapy (HAART). Thus, there is a need to evaluate other less expensive surrogate markers like total lymphocyte count (TLC) and absolute lymphocyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Sreenivasan, Srirangaraj, Dasegowda, Venkatesha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162814/
https://www.ncbi.nlm.nih.gov/pubmed/21887059
http://dx.doi.org/10.4103/0974-777X.83533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162814/
https://www.ncbi.nlm.nih.gov/pubmed/21887059
http://dx.doi.org/10.4103/0974-777X.83533

Ejemplares similares